6 European Projects Found
Searched on 125080 European Projects
FINISHED
European Medicines Research Training Network (EMTRAIN)
Start date: Oct 1, 2009, End date: Sep 30, 2016,
EMTRAIN is an essential element for the success of the IMI Education & Training (E&T) Call Topics in Europe (current and future). It will establish a pan-European platform of excellence for education and training covering the whole life-cycle of medicines from basic research through clinical development to pharmaco-vigilance. It will underpin the successful delivery of the current and future IMI-f ...
Read Project
32
Partners Participants
FINISHED
Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
The trypanosomatid diseases, leishmaniasis, Human African trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (Califor ...
Read Project
14
Partners Participants
FINISHED
SAFER AND FASTER EVIDENCE-BASED TRANSLATION (SAFE-T)
Start date: Jun 15, 2009, End date: Jun 14, 2015,
The public-private consortium composed of complementary SMEs, academic and clinical centers of excellence and EMEA as partner proposes SAFE-T (Safer And Easter Evidence-based Iranslation) project for the establishment of a biomarker (BM) qualification process and its validation in clinical biomarker studies designed for the translation, performance testing and eventual regulatory qualifIcatIon of ...
Read Project
26
Partners Participants
FINISHED
Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities (EPOCAN)
Start date: Oct 1, 2011, End date: Sep 30, 2014,
EpoCan aims to develop and implement a comprehensive interdisciplinary strategy to assess the long-term risks of erythropoietin (EPO) and its derivatives (epoetins) on tumour growth progression and thromboembolic events in cancer patients, cardiovascular events, and the development of cancer in chronic kidney disease. Approximately 400,000 patients across Europe receive epoetins treatment each yea ...
Read Project
13
Partners Participants
FINISHED
Pharmaceutical Medicine Training Programme (PHARMATRAIN)
Start date: May 1, 2009, End date: Apr 30, 2014,
"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety and regulatory scientists from universities, regulatory agencies, large, middle-sized and small pharmaceutical enterprises, ...
Read Project
52
Partners Participants
FINISHED
EUROpean multilevel integrated BIOREFinery design for sustainable biomass processing (EuroBioRef)
Start date: Mar 1, 2010, End date: Feb 28, 2014,
The development and implementation of bio-refinery processes is an absolute necessity and the key to meet the vision towards bio-based economy. The EuroBioRef concept is an integrated, sustainable and diversified bio-refinery involving all biomass value chain stakeholders. The latter will allow large-scale research, testing, optimisation and demonstration of processes in the production of a wide r ...
Read Project
